Advancing Community Healthcare Through Strategic PartnershipAdvancing Community Healthcare: Ionic Global Partners PERDIM to Elevate Wound Care Standards in MalaysiaAdvancing Community Healthcare Through Strategic Partnership
Ionic Global collaborates with PERDIM to promote wound care awareness, clinical education, and Antaviro HOCl-based antimicrobial solutions—advancing healthcare standards and community well-being in Malaysia. Advancing Community Healthcare Through Strategic Collaboration At Ionic Global Sdn Bhd (IG), we believe that true progress begins with giving back to the communities we serve. Guided by this principle, we are honoured to mark a significant milestone on 25 April 2026 with the signing of a Memorandum of Understanding (MOU) with PERDIM (Pertubuhan Doktor-Doktor Islam Malaysia), representing approximately 1,200 private clinics nationwide. This strategic collaboration reflects a shared commitment to advancing community healthcare through structured Corporate Social Responsibility (CSR) initiatives. By combining clinical expertise, professional networks, and innovation-driven solutions, Ionic Global and PERDIM aim to strengthen awareness and adoption of proper wound care management—an essential component in improving patient outcomes yet often underemphasised at the community level. Central to this partnership is a focus on education, training, and the development of more consistent, evidence-informed practices. Through targeted programmes, practitioner engagement, and knowledge-sharing platforms, both parties seek to enhance clinical understanding while empowering healthcare providers with practical approaches to wound care that prioritise safety, effectiveness, and patient well-being. Supporting these efforts is Ionic Global’s continued advancement in antimicrobial wound hygiene, particularly through the application of hypochlorous acid (HOCl) technology. Recognised in scientific literature as a naturally occurring antimicrobial agent involved in the body’s innate immune response, HOCl demonstrates broad-spectrum antimicrobial activity against common wound pathogens. At controlled concentrations, it has been associated with rapid microbial reduction under appropriate conditions, while maintaining favourable tissue compatibility and low cytotoxicity—key considerations in preserving viable tissue during the healing process. As the key active component in Antaviro Wound Care, IGTech Antimicrobial Solution—powered by hypochlorous acid (HOCl)—is designed to support hygienic wound environments by contributing to microbial load management and helping to mitigate biofilm-prone conditions, which are commonly associated with delayed healing. This approach aligns with contemporary wound care principles that emphasise maintaining a balanced wound environment to support natural healing progression. Within the context of this collaboration, both Ionic Global and PERDIM will work towards building a growing body of clinical insights through practitioner feedback, observational data, and structured engagement initiatives. These efforts are complemented by awareness campaigns and training sessions aimed at improving sensitivity, consistency, and confidence in wound care practices. By leveraging PERDIM’s extensive professional network and communication platforms, the collaboration seeks to extend its impact beyond clinical settings and into the broader community. The MOU signing took place during PERDIM’s Annual Raya celebration, where Ionic Global was represented by Director, Mr. Baharinshah Hussain, alongside Business Development Advisor, Mdm Monica Low. In conjunction with the celebration, Ionic Global also presented 10 Raya gift hampers featuring Antaviro Wound Care and the Ombac+ product series—including Instant Hygiene Spray, Feminine Care, Men Care, and Fur Fur Pet Care—as a gesture of appreciation to the medical community for their continued dedication and service. This partnership represents more than a formal agreement—it reflects a shared purpose to contribute meaningfully to healthcare development in Malaysia. Through collaboration, continuous learning, and responsible innovation, Ionic Global remains committed to supporting improved clinical practices, enhancing patient care, and fostering a more informed and resilient healthcare ecosystem. As we move forward, we look to this collaboration as a foundation for long-term impact—one that brings together science, care, and community to shape a healthier future for all.
